bioRxivMicrobiology
Direct evidence of abortive lytic infection-mediated establishment of Epstein-Barr virus latency during B-cell infection
T. Inagaki, Y. Sato, J. Ito, M. Takaki, Y. Okuno, M. Yaguchi, H. M. A. A. Masud, T. Watanabe, K. Sato, S. Iwami, T. Murata, H. Kimura
Abstract
Viral infection induces dynamic changes in transcriptional profiles. Virus-induced and anti-viral responses are intertwined during the infection. Epstein-Barr virus (EBV) is a human gammaherpesvirus that provides a model of herpesvirus latency. To measure the transcriptome changes during the establishment of EBV latency, EBV-negative Akata cells were infected with EBV-EGFP and observed by transcriptome sequencing (RNA-seq) at 0, 2, 4, 7, 10, and 14 days after infection. We found transient downregulation of mitotic division-related genes, reflecting reprograming of cell growth by EBV. Moreover, a burst of viral lytic gene expression was detected in the early phase of infection. Experimental and mathematical investigations demonstrated that infectious virions were not produced in the pre-latent phase, suggesting the presence of an abortive lytic infection. Finally, we conducted fate mapping using recombinant EBV, enabling the noninvasive, continuous observation of infected cells during EBV infection. Our tracking analysis provided direct evidence that the abortive lytic infection in the pre-latent phase converges to latent infection during EBV infection of B-cells, shedding light on novel roles of viral lytic gene(s) in establishing latency. Author summaryViral infection is a complex process that activates both virus-triggered and host anti-viral responses. This process has classically been studied by snapshot analysis such as microarray and RNA-seq at discrete time points as population averages. Snapshot data lead to invaluable findings in host-pathogen interactions. However, these "snapshot" omics, even from a single cell, lack temporal resolution. Because the behavior of infected cells is highly dynamic and heterogenous, continuous analysis is required for deciphering the fate of infected cells during viral infection. Here, we exploited fate mapping techniques with recombinant Epstein-Barr virus (EBV) to track the infected cells and recorded a log of lytic gene expression during EBV infection. Our continuous observation of infected cells revealed that EBV established latency in B-cells via an abortive lytic infection in the pre-latent phase.
- organism: human
- assay: bulk RNA-seq
- research focus: host-pathogen & immune response
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Epstein-Barr virus reprograms human B-lymphocytes immediately in the pre-latent phase of infection
P. Mrozek-Gorska, A. Buschle, … W. Hammerschmidt·bioRxiv·Dec 31, 2018
- Epstein-Barr virus inactivates the transcriptome and disrupts the chromatin architecture of its host cell in the first phase of lytic reactivation
A. Buschle, P. Mrozek-Gorska, … W. Hammerschmidt·bioRxiv·Mar 20, 2019
- Epstein-Barr virus reactivation induces divergent abortive, reprogrammed, and host shutoff states by lytic progression
Elliott Daniel SoRelle, Lauren E. Haynes, … Micah A. Luftig·PLoS PathogensPeer-reviewed·Oct 24, 2024
- The first days in the life of naïve human B-lymphocytes infected with Epstein-Barr virus
D. Pich, P. Mrozek-Gorska, … W. Hammerschmidt·bioRxiv·Jun 11, 2019
- Fate-resolved gene regulatory signatures of individual B lymphocytes in the early stages of Epstein-Barr Virus infection
E. D. SoRelle, J. Dai, … M. A. Luftig·bioRxiv·Feb 23, 2022
- EBV INFECTION OUTCOMES DETERMINED BY MONOCYTE AND TREG-DRIVEN IMMUNE DYNAMICS IN AN EX VIVO PBMC MODEL
Leena Yoon, Lauren N. MacMullen, … Paul M. Lieberman·bioRxiv·Nov 20, 2025